AD GWAS provided convincing proof of a connection between AD and PICALM variations, indicating that PICALM plays an essential part in eliminating APP‐β‐CTF and that variants in its location are associated with a greater likelihood of AD [292, 293]. Here, APP is linked to Alzheimer disease.